• PDF: Delivered by email usually within 48 UK business hours.

Purdue Pharma L.P. - Pharmaceuticals & Healthcare
Deals and Alliances Profile

  • Publication Date:March 2011
  • Publisher:GlobalData
  • Product Type: Report
  • Pages:57

Purdue Pharma L.P. - Pharmaceuticals & Healthcare Deals and Alliances Profile

Purdue Pharma L.P. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Purdue Pharma L.P. (Purdue) is a pharmaceutical company, principally engaged in the research, development, manufacture and marketing of prescription medicines for chronic and severe pain. The company also markets and sells various non-prescription products, such as Betadine topical antiseptic, and Colace and Senokot lines of laxatives; and hospital products. The company operates three manufacturing facilities in North Carolina, New Jersey and Rhode Island in the US. Its research and development (R&D) efforts focus on the advancement of technologies in drug delivery and development of innovative medicines for the treatment of pain and other conditions. Purdue is headquartered in Stamford, the US.

Purdue Pharma L.P. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you an in-depth data and trend analysis of the company's mergers and acquisitions (M&A) and financings. The report provides detailed information on M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions registered by the company over a five year period. The report portrays detailed comparative data on the number of deals and their value subdivided by deal types, markets, and regions, besides highlighting the company's major recent financial deals.

Data presented in this report was derived from GlobalData's proprietary in-house Pharmaceuticals and Healthcare eTrack deals database and primary and secondary research.

Scope

  • Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information on the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information on the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region for North America, Europe, the Middle East and Africa and South and Central America.
  • Deals by Market - Chart and table showing information on the number of deals and value reported by the company, by market.
  • Major Recent Deals - Information on the company's major recent financial deals. Each such deal has a brief summary, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key Competitors - A list of key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements.

  • The profile analyzes the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divesture strategy

  • Deals are presented from the company's core business segments' perspective to help you understand its corporate strategy

Access detailed information about the company's recent financial deals that enables you to understand the key deals which have shaped the company

  • Major recent deals are presented in detail, which provides information on each deal's brief summary, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company to identify potential customers and suppliers.

  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and their biographies and key competitors.

Stay up to date on the major developments affecting the company

  • Recent developments in the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research.

  • Key elements such as break up of deals by categories and information on detailed major deals are incorporated in the profile to assist your academic or business research needs.
  • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare Deals By Type, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Region, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Partnerships, Deals By Therapy Area Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Partnerships, Deals By Phase Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Year Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Therapy Area Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Phase Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals Summary, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deal Details
    • Venture Financing
    • Kolltan Pharmaceuticals Raises $40 Million In Series A Financing
    • Partnerships
    • Mundipharma International And Purdue Pharmaceutical Exercises Rights To Infinity's FAAH Program
    • Mundipharma Enters Into Agreement With Purdue Pharma
    • Infinity Pharmaceuticals Enters Into Collaboration Agreement With Mundipharma And Purdue Pharmaceutical
    • Shionogi Enters Into Co-Development Agreement With Purdue Pharma
    • Purdue Pharma Enters Into Agreement With Watson Pharmaceuticals
    • Licensing Agreements
    • Purdue Pharma Enters Into License Agreement With Transcept Pharmaceuticals
    • Impax Laboratories Enters Into Licensing Agreement With Purdue Pharma
    • Labopharm Enters Into A License And Distribution Agreement With Purdue Pharma
    • Equity Offering
    • Novelos Therapeutics Completes Second Tranche Of Private Placement For $5.5 Million
    • Infinity Pharmaceuticals Completes Second Equity Financing Of $30 Million
    • Divestiture - Assets
    • Rocky Mountain Poison Acquires RADARS System From Purdue Pharma
    • Key Competitors
    • Key Employees
    • Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
    • Recent Developments
    • Strategy And Business Planning
    • Aug 02, 2009: Purdue Signs Licence, Collaboration Agreement With Transcept
    • Corporate Communications
    • Jan 21, 2010: Purdue Donates Close To $5 Million In Pharmaceutical Products To Earthquake Victims In Haiti
    • Legal and Regulatory
    • Jun 04, 2010: Labopharm Comments On Judgment In Purdue Appeal of Decision Relating To Patents
    • Jan 04, 2010: Cipher Obtains Favourable Ruling In CIP-TRAMADOL ER Patent Litigation
    • Aug 17, 2009: Par Wins Favorable Ruling In Ultram ER Litigation
    • Aug 17, 2009: PAR Receives Favourable Judgement In Ultram ER Litigation
    • Jun 09, 2009: KV Pharmaceutical Company And Purdue Pharma Settle OxyContin Dispute
    • Sep 02, 2008: Purdue Pharma L.P. Announces Resolution Of Oxycontin® Patent Lawsuit With Mallinckrodt Inc
    • Apr 02, 2007: Purdue Pharma L.P. Announces Agreement To End Oxycontin® Patent Lawsuit With Impax Laboratories
    • Oct 16, 2006: Purdue Pharma L.P. Announces Signing Of Consent Judgment Ending Oxycontin® Tablets Patent Lawsuit With Teva Pharmaceuticals
    • Aug 29, 2006: Purdue Pharma L.P. Announces Agreement To End Oxycontin® Patent Lawsuit With Teva Pharmaceuticals
    • Aug 28, 2006: Purdue Pharma L.P. Announces Resolution Of Oxycontin® Patent Lawsuit With Endo Pharmaceuticals
    • May 16, 2000: Purdue Pharma Successfully Defends Patent Position For Sustained Release Oxycodone; Federal Judge Issues Preliminary Injunction Blocking Boehringer Ingelheim From Launching Roxicodone Sr
    • Government and Public Interest
    • Nov 17, 2009: Purdue Pharma Files Patent Infringement Litigation Against Sun Pharma
    • Aug 17, 2009: Par Pharmaceutical Wins On Invalidity In Ultram ER Litigation
    • Product News
    • Dec 03, 2001: Purdue Pharma Begins Clinical Studies Of Abuse-Resistant Pain Medication
    • Nov 30, 2005: New Drug Application For Once-Daily Tramadol Pain Medication Submitted By Purdue's Marketing Partner
    • Nov 15, 2004: Purdue Pharma L.P. Implements Radio Frequency Id System For Drug Packaging To Deter Counterfeiting And Diversion Company Leads Industry In Complying With Fda Counterfeit Drug Task Force Recommendations Issued Today
    • Nov 07, 2003: Purdue Launches Spectracef Oral Antibiotic In The U.S
    • Nov 07, 2000: Dr. Lynn Kramer Named Vp, Medical Research For Purdue Pharma
    • Sep 24, 2009: Statement Of Purdue Pharma L.P. Regarding Joint Meeting Of The U.S. Food And Drug Administration's (Fda) Anesthetic And Life Support Drugs Advisory Committee And The Drug Safety And Risk Management Advisory Committee
    • Sep 24, 2004: Fda Approves Palladone (Hydromorphone Hcl Extended-Release) Capsules (Cii) For The Management Of Persistent, Moderate To Severe Pain
    • Aug 08, 2001: International Patent Application To Be Published On Abuse-Resistant Pain Reliever Being Developed By Purdue Pharma
    • Jul 13, 2005: Purdue Pharma L.P. Suspends Marketing Of Palladone Capsules
    • Jul 01, 2010: Purdue Pharma L.P. Receives Fda Approval For Butrans (Buprenorphine) Transdermal System Ciii
    • Apr 05, 2010: Statement Of Purdue Pharma L.P. Regarding Fdas Approval Of Reformulated Oxycontin (Oxycodone Hcl Controlled-Release) Tablets
    • Apr 02, 2004: Purdue Pharma L.P. Files, Serves Appeal Brief In Endo Case
    • Mar 10, 2008: Three New Dosage Strengths Introduced For Oxycontin Cii (Oxycodone Hcl Controlled-Release) Tablets
    • Feb 26, 2003: Five Oxycontin Cases Against Purdue Pharma Dismissed
    • Feb 09, 2001: Appalachian Pain Foundation Announces Proper pain Management, Prescription Drug Abuse Prevention Initiative
    • Jan 12, 2004: Purdue Pharma Files Notice Of Appeal In Endo Patent Case; Commits To Expedited Process
    • Jan 09, 2004: Purdue Files Petition With Fda Requesting Risk Management Plans For All Generic Forms Of Oxycontin
    • Jan 07, 2008: Statement Of Purdue Pharma L.P. In Response To The Decision Confirming The Enforceability Of Its Oxycontin Patents
    • Jan 07, 2004: Statement Regarding U.S. District Court Ruling On Purdue Patents For Oxycontin Tablets
  • Appendix
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer 57
  • List of Tables
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Key Facts
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Region, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare Deals By Type, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Region, 2005 to YTD 2011
    • Purdue Pharma L.P., Deals By Therapy Area, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Partnerships, Deals By Year Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Partnerships, Deals By Therapy Area Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Partnerships, Deals By Therapy Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Partnerships, Deals By Phase Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Partnerships, Deals By Phase Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Year Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Year Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Therapy Area Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Therapy Area Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Phase Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Licensing Deals, Deals By Phase Vs Deal Value Vs Upfront Payment, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals Summary, 2005 to YTD 2011
    • Kolltan Pharmaceuticals Raises $40 Million In Series A Financing
    • Mundipharma International And Purdue Pharmaceutical Exercises Rights To Infinity's FAAH Program
    • Mundipharma Enters Into Agreement With Purdue Pharma
    • Infinity Pharmaceuticals Enters Into Collaboration Agreement With Mundipharma And Purdue Pharmaceutical
    • Shionogi Enters Into Co-Development Agreement With Purdue Pharma
    • Purdue Pharma Enters Into Agreement With Watson Pharmaceuticals
    • Purdue Pharma Enters Into License Agreement With Transcept Pharmaceuticals
    • Impax Laboratories Enters Into Licensing Agreement With Purdue Pharma
    • Labopharm Enters Into A License And Distribution Agreement With Purdue Pharma
    • Novelos Therapeutics Completes Second Tranche Of Private Placement For $5.5 Million
    • Infinity Pharmaceuticals Completes Second Equity Financing Of $30 Million
    • Rocky Mountain Poison Acquires RADARS System From Purdue Pharma
    • Purdue Pharma L.P., Key Employees
    • Purdue Pharma L.P., Other Locations 35
  • List of Figures
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Licensing Deals by Year, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Licensing Deals by Phase, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Region, 2005 to YTD 2011
    • Purdue Pharma L.P., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2005 to YTD 2011
+44 20 8816 8548

Ask a question about Purdue Pharma L.P. - Pharmaceuticals & Healthcare

Enter the characters you see in the picture below
Captcha